{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+I&page=25", "query": { "intervention": "Control I", "page": 25 }, "page_size": 10 }, "pagination": { "page": 25, "page_size": 10, "total_count": 2206, "total_pages": 221, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+I&page=26&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+I&page=24&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-24T21:07:12.974Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03651076", "title": "Traxi Panniculus Retractor for Cesarean Delivery", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity, Morbid", "Cesarean Section Complications" ], "interventions": [ { "name": "Traxi panniculus retraction (Clinical Innovations, LLC)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 142, "start_date": "2018-10-02", "completion_date": "2025-02-01", "has_results": true, "last_update_posted_date": "2026-06-24", "last_synced_at": "2026-10-24T21:07:12.974Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03651076" }, { "nct_id": "NCT06904391", "title": "Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Other" ], "interventions": [ { "name": "Educational Intervention", "type": "OTHER" }, { "name": "Behavioral Intervention", "type": "OTHER" }, { "name": "Survey Administration", "type": "OTHER" }, { "name": "Interview", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 97, "start_date": "2025-09-05", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-10-24T21:07:12.974Z", "location_count": 44, "location_summary": "Newark, Delaware • Hinesville, Georgia • Jesup, Georgia + 37 more", "locations": [ { "city": "Newark", "state": "Delaware" }, { "city": "Hinesville", "state": "Georgia" }, { "city": "Jesup", "state": "Georgia" }, { "city": "Savannah", "state": "Georgia" }, { "city": "Honolulu", "state": "Hawaii" } ], "official_url": "https://clinicaltrials.gov/study/NCT06904391" }, { "nct_id": "NCT04000074", "title": "Contra Costa Health Services Whole Person Care (CommunityConnect) Program Evaluation", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Social Determinants of Health" ], "interventions": [ { "name": "Telephonic Services", "type": "BEHAVIORAL" }, { "name": "In-Person Services", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Contra Costa Health Services", "sponsor_class": "OTHER_GOV", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60000, "start_date": "2017-01-01", "completion_date": "2021-12-31", "has_results": false, "last_update_posted_date": "2019-06-27", "last_synced_at": "2026-10-24T21:07:12.974Z", "location_count": 1, "location_summary": "Concord, California", "locations": [ { "city": "Concord", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04000074" }, { "nct_id": "NCT00133575", "title": "ACAM 3000 MVA at Harvard Medical School", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Smallpox" ], "interventions": [ { "name": "MVA Smallpox Vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Live vaccinia virus vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "38 Years", "sex": "ALL", "summary": "18 Years to 38 Years" }, "enrollment_count": 72, "start_date": "2005-10", "completion_date": "2008-04", "has_results": true, "last_update_posted_date": "2015-01-05", "last_synced_at": "2026-10-24T21:07:12.974Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00133575" }, { "nct_id": "NCT01064401", "title": "Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Relapsing-Remitting Multiple Sclerosis" ], "interventions": [ { "name": "BIIB019 (Daclizumab High Yield Process)", "type": "BIOLOGICAL" }, { "name": "Interferon beta-1a Placebo", "type": "DRUG" }, { "name": "Interferon beta-1a", "type": "BIOLOGICAL" }, { "name": "Daclizumab High Yield Process Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 1841, "start_date": "2010-05", "completion_date": "2014-07", "has_results": true, "last_update_posted_date": "2016-07-11", "last_synced_at": "2026-10-24T21:07:12.974Z", "location_count": 46, "location_summary": "Gilbert, Arizona • Phoenix, Arizona • Tucson, Arizona + 43 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01064401" }, { "nct_id": "NCT05984030", "title": "Supporting Tailored And Responsive PrEP in Rural North Carolina", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Pre-Exposure Prophylaxis" ], "interventions": [ { "name": "PrEP Navigation Services", "type": "OTHER" }, { "name": "Telehealth PrEP Services Referral", "type": "OTHER" }, { "name": "HealthMpowerment Digital Health Intervention - Enhanced", "type": "BEHAVIORAL" }, { "name": "HealthMpowerment Digital Health Intervention - Basic", "type": "BEHAVIORAL" } ], "intervention_types": [ "OTHER", "BEHAVIORAL" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "39 Years", "sex": "ALL", "summary": "18 Years to 39 Years" }, "enrollment_count": 17, "start_date": "2023-08-31", "completion_date": "2025-06-01", "has_results": true, "last_update_posted_date": "2025-08-15", "last_synced_at": "2026-10-24T21:07:12.974Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05984030" }, { "nct_id": "NCT02101775", "title": "Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ovarian Brenner Tumor", "Ovarian Clear Cell Cystadenocarcinoma", "Ovarian Endometrioid Adenocarcinoma", "Ovarian Malignant Mixed Mesodermal (Mullerian) Tumor", "Ovarian Mucinous Cystadenocarcinoma", "Ovarian Seromucinous Carcinoma", "Ovarian Serous Cystadenocarcinoma", "Ovarian Serous Surface Papillary Adenocarcinoma", "Ovarian Undifferentiated Carcinoma", "Recurrent Fallopian Tube Carcinoma", "Recurrent Ovarian Carcinoma", "Recurrent Primary Peritoneal Carcinoma" ], "interventions": [ { "name": "Adavosertib", "type": "DRUG" }, { "name": "Gemcitabine Hydrochloride", "type": "DRUG" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Pharmacological Study", "type": "OTHER" }, { "name": "Placebo Administration", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 124, "start_date": "2014-07-21", "completion_date": "2027-03-06", "has_results": true, "last_update_posted_date": "2026-09-10", "last_synced_at": "2026-10-24T21:07:12.974Z", "location_count": 8, "location_summary": "Duarte, California • South Pasadena, California • Chicago, Illinois + 5 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "South Pasadena", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Decatur", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02101775" }, { "nct_id": "NCT03400501", "title": "Reducing the Risk of Metabolic Decompensation in Diabetic Adolescents by Supervised School Administration of Insulin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "Insulin Degludec", "type": "DRUG" }, { "name": "Insulin Glargine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "8 Years to 18 Years" }, "enrollment_count": 32, "start_date": "2017-10-01", "completion_date": "2021-06-07", "has_results": false, "last_update_posted_date": "2021-11-05", "last_synced_at": "2026-10-24T21:07:12.974Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03400501" }, { "nct_id": "NCT03078452", "title": "Evaluating Effectiveness of Powered Drill Bone Marrow Biopsy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Plasma Cell Myeloma" ], "interventions": [ { "name": "Power drill", "type": "DEVICE" }, { "name": "Jamshidi needle", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 100, "start_date": "2017-02-14", "completion_date": "2023-12-01", "has_results": true, "last_update_posted_date": "2025-09-08", "last_synced_at": "2026-10-24T21:07:12.974Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03078452" }, { "nct_id": "NCT07650656", "title": "Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "High Grade Sarcoma", "Sarcoma" ], "interventions": [ { "name": "Electronic Health Record Review", "type": "OTHER" }, { "name": "Fluorescence Imaging", "type": "PROCEDURE" }, { "name": "Fluorescence-Guided Surgery", "type": "PROCEDURE" }, { "name": "Indocyanine Green", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Resection", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "PROCEDURE", "DRUG" ], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 22, "start_date": "2026-08-14", "completion_date": "2029-12-17", "has_results": false, "last_update_posted_date": "2026-10-16", "last_synced_at": "2026-10-24T21:07:12.974Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07650656" } ] }